| Date Filed | Type | Description |
| 10/04/2023 |
8-K
| Other Events Interactive Data |
| 08/16/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 08/14/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/31/2023 |
8-K
| Quarterly results |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
8-K
| Termination of a Material Definitive Agreement Interactive Data |
| 07/07/2023 |
4
| ZELEFSKY MICHAEL J (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 7,246 shares
@ $0 |
|
| 07/07/2023 |
4
| Chill Adam J. (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 7,246 shares
@ $0 |
|
| 07/07/2023 |
4
| ROSENWALD LINDSAY A MD (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 7,246 shares
@ $0 |
|
| 07/07/2023 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 7,246 shares
@ $0 |
|
| 07/07/2023 |
4
| Herskowitz Neil (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 7,246 shares
@ $0 |
|
| 07/07/2023 |
4
| Litchman Manuel MD (President and CEO) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 5,000 shares
@ $0 |
|
| 06/30/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/12/2023 |
8-K
| Quarterly results |
| 04/20/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 04/06/2023 |
3/A
| WEISS MICHAEL S (Director) has filed a Form 3/A on MUSTANG BIO, INC. |
| 04/06/2023 |
3/A
| ROSENWALD LINDSAY A MD (Director) has filed a Form 3/A on MUSTANG BIO, INC. |
| 04/03/2023 |
4
| Litchman Manuel MD (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Bought 5,000 shares
@ $0.739, valued at
$3.7k
Granted 61,000 shares
@ $0
Bought 5,000 shares
@ $0.5164, valued at
$2.6k
|
|
| 04/03/2023 |
4
| ROSENWALD LINDSAY A MD (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Bought 4,094 shares
@ $0.739, valued at
$3k
Granted 71,664 shares
@ $0
Bought 5,000 shares
@ $0.5164, valued at
$2.6k
|
|
| 04/03/2023 |
4
| Herskowitz Neil (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 71,664 shares
@ $0 |
|
| 04/03/2023 |
4
| ZELEFSKY MICHAEL J (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 71,664 shares
@ $0 |
|
| 04/03/2023 |
4
| Chill Adam J. (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 71,664 shares
@ $0 |
|
| 04/03/2023 |
4
| WEISS MICHAEL S (Director) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 71,664 shares
@ $0 |
|
| 04/03/2023 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 03/29/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
DEF 14C
| Form DEF 14C - Other definitive information statements: |
| 01/13/2023 |
SC 13D/A
| Fortress Biotech, Inc. reports a 20.7% stake in MUSTANG BIO, INC. |
| 01/06/2023 |
4
| Fortress Biotech, Inc. (10% Owner) has filed a Form 4 on MUSTANG BIO, INC.|
Txns:
| Granted 2,807,008 shares
@ $0 |
|
| 12/13/2022 |
8-K
| Quarterly results |
| 11/25/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
|